๐ Statistics
- Analyst 1 Year Price Target:
$0.07
- Upside/Downside from Analyst Target:
25.42%
- Broker Call:
2
- Dividend Minimum 3 Year Yield:
0.00%
- EPS Growth Range (1Y):
<0%
- Net Income Growth Range (1Y):
<0%
- Revenue Growth Range (1Y):
10-25%
-
Upcoming Earnings Date:
-
๐ฐ Dividend History
Current year to date yield:
0.75%
๐
SGX Earnings Announcements for A50
Thomson Medical Group Limited (A50)
Market: SGX |
Currency: SGD
Address: 101 Thomson Road
Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore and Malaysia. It operates in Hospital Services and Specialised Services segments. The company owns and operates the Thomson Medical Centre, as well as a network of 37 clinics and centers that provide integrated medical healthcare facilities and services, such as obstetrics, gynaecology, paediatric, diagnostic imaging, pharmacy, 24-hour outpatient, laboratory, health screening, gynaecological oncology, dentistry, musculoskeletal and sports medicine, and medical aesthetics services, as well as counselling and specialised learning services for children with learning difficulties; and services provided by the fertility clinics, paediatric centres, cancer centres, cardiology centres, traditional Chinese medicine, specialist skin centre services. It also provides consumer products and services. In addition, the company operates a pre-natal and clinical diagnostic laboratory; the Thomson Hospital Kota Damansara, in Kota Damansara, Kuala Lumpur; Thomson Iskandar Medical Hub; fertility centers; and the Vantage Bay Healthcare City located in Iskandar Malaysia. Further, the company provides fertility consultancy, laboratory and embryology, research and development, and property development services. Additionally, it is involved in the information technology and computer service activities; and provision of project related services, including managing vaccination centres, COVID-19 treatment facilities, and transitional care facilities. Thomson Medical Group Limited was founded in 1979 and is based in Singapore.
Show more
๐ Thomson Medical Group Limited Historical Chart
๐งพ Recent Financial Statement Analysis
January 20, 2026
SGX Welcomes Listing of CSOP CSAM CSI A500 Index ETF Under SZSE-SGX ETF Link SGX Welcomes Listing of CSOP CSAM CSI A500 Index ETF Under SZSE-SGX ETF Link Date: 20 January 2026 Key Highlights for Investors Singapore Exchange (SGX) has…
January 16, 2026
CSOP Investments III VCC Appoints New Designated Market Maker for CSOP CSAM CSI A500 Index ETF CSOP Investments III VCC Announces Appointment of New Designated Market Maker for CSOP CSAM CSI A500 Index ETF Key Highlights New Market Maker Appointed:…
September 25, 2025
UOBAM FTSE China A50 Index ETF: FY2025 Financial Analysis & Investor Guidance The UOBAM FTSE China A50 Index ETF, formerly known as United SSE 50 China ETF, has released its annual report for the financial year ended 30 June 2025.…
October 1, 2024
Summary of Key Facts from the Report Report Date and Financial Year The report is dated for the financial year ended on June 30, 2024 (FY2024). Revenue and Profitability The company reported a revenue of $351.2 million in FY2024, showing…
๐ View more in SGX corporate News ๐ View more in SGX Financial statements
๐ฐ Related News & Research
Showing results matched by any of: A50, Thomson Medical Group Limited, Thomson Medical, TMG SP, THOMSON MEDICAL GROUP LTD, THOMSON MEDICAL GROUP
January 20, 2026
SGX Welcomes Listing of CSOP CSAM CSI A500 Index ETF Under SZSE-SGX ETF Link SGX Welcomes Listing of CSOP CSAM CSI A500 Index ETF Under SZSE-SGX ETF Link Date: 20 January 2026 Key Highlights for Investors Singapore Exchange (SGX) has…
January 16, 2026
CSOP Investments III VCC Appoints New Designated Market Maker for CSOP CSAM CSI A500 Index ETF CSOP Investments III VCC Announces Appointment of New Designated Market Maker for CSOP CSAM CSI A500 Index ETF Key Highlights New Market Maker Appointed:…
September 25, 2025
UOBAM FTSE China A50 Index ETF: FY2025 Financial Analysis & Investor Guidance The UOBAM FTSE China A50 Index ETF, formerly known as United SSE 50 China ETF, has released its annual report for the financial year ended 30 June 2025.…
March 19, 2025
Johor Bahru could soon rival Kuala Lumpur and Penang as a major medical hub, as healthcare players, including Thomson Medical Group, eye the Johor-Singapore Special Economic Zone (JS-SEZ) for expansion. Thomson Medical, controlled by Singaporean billionaire Peter Lim, is developing…
October 1, 2024
Summary of Key Facts from the Report Report Date and Financial Year The report is dated for the financial year ended on June 30, 2024 (FY2024). Revenue and Profitability The company reported a revenue of $351.2 million in FY2024, showing…